Cepheid Receives FDA Clearance for Xpert® GI Panel to Support Broad Detection of Gastrointestinal Pathogens

Cepheid announced today that it has received FDA clearance for Xpert GI Panel, a multiplex PCR test designed to provide fast ...
Medical Device Network on MSN

FDA clears Cepheid’s Xpert GI panel for pathogen detection

The Xpert GI Panel identifies pathogens directly from stool specimens collected in Cary-Blair transport media.
360Dx

Cepheid Enters Rapid Syndromic Testing Space With FDA Clearance of GI Panel

The Danaher subsidiary aims to meet clinician needs for flexibility with a range of test size options for its vast installed base.
Healio

DNA methylation test identifies origins of gastric cancer, other GI malignancies

Please provide your email address to receive an email when new articles are posted on . Testing correctly identified 79% of patients with GI cancer as positive. Nearly all (96%) of healthy controls ...
Labroots

Navigating the Molecular Frontier: From Poo to Precision - A Journey in GI Test Implementation

In the rapidly expanding landscape of molecular diagnostics, the focus is shifting from top to bottom, with a redirection from post-pandemic respiratory testing to developments in gastrointestinal (GI ...
Healio

‘Double whammy:’ CTA use for GI bleeds rise, but diagnostic yield drops

Please provide your email address to receive an email when new articles are posted on . The use of CT angiography to detect acute GI bleeding increased by about seven times over 7 years in a ...